(Q33338804)
Statements
Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma (English)
S Sacchi
M Federico
U Vitolo
C Boccomini
D Vallisa
M Petrini
S Rupoli
F Di Raimondo
F Merli
V Liso
A Tabilio
G Saglio
G Vinci
M Brugiatelli
G Dastoli
1 September 2001